Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hormone replacement therapy for menopausal women

J Hirata¹, K S Moghissi

¹Department of Obstetrics & Gynecology, Wayne State University School of Medicine, Hutzel Hospital, Detroit, Michigan.

Comprehensive Therapy

|December 1, 1992

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing Regimens.

CPT: pharmacometrics & systems pharmacology·2017

Same author

Integrated Two-Analyte Population Pharmacokinetic Model for Antibody-Drug Conjugates in Patients: Implications for Reducing Pharmacokinetic Sampling.

CPT: pharmacometrics & systems pharmacology·2016

Same author

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.

British journal of cancer·2015

Same author

UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study.

European journal of gynaecological oncology·2013

Same author

Prognosis of high-grade endometrial cancer: a comparison of serous-type and clear cell type to grade 3 endometrioid-type.

European journal of gynaecological oncology·2013

Same author

Elevation of interleukin-2 production in peripheral-blood lymphocytes by recombinant human granulocyte-colony-stimulating factor in ovarian-cancer patients during combination chemotherapy.

Oncology reports·2011